Vanguard Group Inc Enanta Pharmaceuticals Inc Put Options Transaction History
Vanguard Group Inc
- $6.44 Trillion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ENTA
# of Institutions
117Shares Held
19MCall Options Held
123KPut Options Held
33.1K-
Farallon Capital Management LLC San Francisco, CA2.12MShares$25.6 Million0.11% of portfolio
-
Krensavage Asset Management, LLC New York, NY2.11MShares$25.5 Million8.46% of portfolio
-
Janus Henderson Group PLC London, X01.95MShares$23.5 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$22.3 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny948KShares$11.4 Million0.01% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $250M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...